Medirom Healthcare Technologies (MRM) Gains from Investment Securities (2019 - 2023)

Medirom Healthcare Technologies' Gains from Investment Securities history runs 5 years deep, the most recent figure standing at $47.02 for Q4 2023.

• In Q4 2023, Gains from Investment Securities fell 98.88% year-over-year to $47.02; the TTM figure through Dec 2023 stood at $47.02 (down 98.88% YoY), while the FY2024 annual figure was $349582.4, up 13.03% from the prior year.
• Gains from Investment Securities was $47.02 for Q4 2023 at Medirom Healthcare Technologies, down from $4199.2 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $5276.6 in Q4 2021 to a low of $47.02 in Q4 2023.
• Historically, Gains from Investment Securities has averaged $3415.7 across 5 years, with a median of $4199.2 in 2022.
• The sharpest annual moves came in 2021 and 2023: Gains from Investment Securities jumped 90.13% in 2021, then plunged 98.88% in 2023.
• A 5-year view of Gains from Investment Securities shows it stood at $4780.1 in 2019, then slumped by 41.94% to $2775.3 in 2020, then surged by 90.13% to $5276.6 in 2021, then fell by 20.42% to $4199.2 in 2022, then slumped by 98.88% to $47.02 in 2023.
• The last three Gains from Investment Securities figures came in at $47.02 (Q4 2023), $4199.2 (Q4 2022), and $5276.6 (Q4 2021), per Business Quant data.